We are pleased to announce that SpiroChem will be participating in Drug Discovery Chemistry 2026, taking place in San Diego, California, from April 13–16, 2026.
Organised by the Cambridge HealthTech Institute (CHI), Drug Discovery Chemistry is a dynamic event bringing together medicinal, biophysical, and computational chemists from across pharma, biotech, and academia.
Focused on discovery and optimization challenges of small-molecule and macrocyclic drug candidates, the conference highlights innovative approaches in AI- and ML-driven design, fragment- and structure-based discovery, molecular glues and degraders, DNA-encoded libraries, and emerging biophysical tools.
The 2026 edition will feature a comprehensive scientific program including expert presentations, interactive discussions, and dedicated networking opportunities, offering a valuable platform for knowledge exchange and collaboration across the international drug discovery community.
Meet our team on-site:
Thomas Fessard, PhD –Chief Executive Officer
Gerhard Müller, PhD –Chief Scientific Officer
We look forward to engaging with participants in San Diego and discussing how SpiroChem’s expertise in discovery chemistry can contribute to advancing innovative drug discovery programs.
